Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer. - Wikidata - awgldk - TriplyDB

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

http://www.wikidata.org/entity/Q53012804

about

Circulating tumor cells in breast cancer: a tool whose time has come of age Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer Circulating tumor cells: approaches to isolation and characterization Circulating tumor cells: finding the needle in the haystack Circulating tumor cells in germ cell tumors: are those biomarkers of real prognostic value? A review Evaluation and consequences of heterogeneity in the circulating tumor cell compartment Circulating tumor cells isolation: the "post-EpCAM era"Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer Epithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistance Biosensors for the detection of circulating tumour cells.Circulating Tumor Cells: A Window Into Tumor Development and Therapeutic Effectiveness Circulating tumors cells as biomarkers: progress toward biomarker qualification Detection of circulating tumor cells Chemoaffinity capture of pre-targeted prostate cancer cells with magnetic beads A critical review of the analytical approaches for circulating tumor biomarker kinetics during treatment Resection of the primary tumor in stage IV breast cancer Emerging technologies for CTC detection based on depletion of normal cells Minimal residual disease and circulating tumor cells in breast cancer The promise of circulating tumor cell analysis in cancer management Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research Progress in circulating tumor cell capture and analysis: implications for cancer management Significance of circulating tumor cells in soft tissue sarcoma.Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion Potential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current Evidence Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway Circulating tumor cells: application as a biomarker for molecular characterization and predictor of survival in an all-comer solid tumor phase I clinical study Unbiased and automated identification of a circulating tumour cell definition that associates with overall survival Fundamentals and application of magnetic particles in cell isolation and enrichment: a review Dynamic Fluctuation of Circulating Tumor Cells during Cancer Progression.Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis.Photoacoustic imaging: a potential tool to detect early indicators of metastasis.Isolation and retrieval of circulating tumor cells using centrifugal forces.Circulating tumor cell data: integration with imaging and serum tumor markers for metastatic breast cancer patient management.Integrating circulating tumor cell data with imaging and serum prostate-specific antigen measurement for metastatic prostate cancer therapy management Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.Clinical relevance and current challenges of research on disseminating tumor cells in cancer patients Circulating tumor cell analysis: technical and statistical considerations for application to the clinic.MUC1-positive circulating tumor cells and MUC1 protein predict chemotherapeutic efficacy in the treatment of metastatic breast cancer.Circulating Tumor Cells in Early-Stage Breast Cancer.

P2860

Q21245253-8290B15B-95E6-45C0-9F36-8BCFBFEE5682 Q21296854-FE348767-58BB-4BF4-8C05-7BB2A47586F5 Q24631347-3A4D75D3-8395-475E-B250-E64189D7D6F5 Q24634952-6683BA7E-8556-433A-9A7A-8F3672576F8B Q26752116-2F78A1D7-5187-4BD0-9D06-93DBABDC7B32 Q26765357-120F1ECD-FBAB-4D6C-B847-16EC6CE23C4A Q26778917-8F0A4587-660E-4D35-ABEE-8F92791A4C33 Q26781088-8D72AD44-E15B-4981-A91D-2785AEAC38B8 Q26824386-3D2D0A66-59DC-489A-9141-492A3E7C32F6 Q26827228-0CE85045-834D-4CE9-99C3-44931F7DAB3C Q26827815-535333C7-69D1-46C5-B79F-83E7D95332DA Q26852579-AE681955-0FBF-432C-934D-00934E9270D0 Q26859334-E0A7CBD5-F293-4E2C-BDC0-0B934A408CD1 Q26861322-4ED99E38-2793-46DA-A6AF-15F02797BE8D Q26862558-45B4CC2C-6D61-45C8-9F5B-0108FCF4CA28 Q26996669-E17002DF-DFFA-40C7-8B5F-6B9989DC853B Q27009519-4F749BC2-1828-4E84-929F-99A1781C5CEE Q27010152-0CB7C83F-913B-4088-A311-E96C497F3769 Q27022113-4429C01C-318F-4795-9357-4792A9D8136E Q27024191-5DBA17AD-DCD5-484A-B672-2DF7C9904AA7 Q27025737-22F39D1F-750F-47BD-A4EA-B520BCE35D36 Q27693309-0E03D7EC-F7BF-4288-ACB4-E76CC67CAC50 Q28066285-0E266552-A84A-4098-8791-2C5C2B608126 Q28075850-DF3FCC59-6705-4EDD-9E53-0F5BB176D67D Q28382812-37B98CF4-30C5-4E40-AAB5-B841D8613401 Q28535476-DA0F275E-46F0-4188-8359-C92451F72FE7 Q28743067-F88C0F8E-D204-4B82-909C-43938501953D Q30395055-4CA7BF83-5C0D-4BEA-A2AF-E65DD2A51656 Q30440326-0C21AD9D-767D-4FD0-8BD1-38B750D99C03 Q30445250-D5B8B975-2FC9-4687-B872-07947CFA6FD9 Q30447713-FB5E12BD-7689-456C-9900-77EEB490833E Q30535350-4B58A687-98FF-40F5-A87B-D50424E2AA62 Q30815483-BAA90FCF-5E0B-4591-B009-D1F486579783 Q30815486-A07636D6-730B-44F0-90C5-F8F24B239D8E Q31006508-34C63AA7-F1A1-426A-8F70-7885F2AF0A13 Q33551239-2DB0CC0F-8536-4742-A8BA-F060874743BC Q33555492-8167F074-3B6A-4897-97B8-555A7FB0FDBE Q33559406-C1473086-DF4F-435D-A914-925AACA95C09 Q33574926-2B753AEF-BD5A-4735-9B69-30D8AA0DA671 Q33579111-A463EA00-6F3B-4E12-A38C-45026E965379

P2860

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

http://www.wikidata.org/entity/Q53012804

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Circulating tumor cells versus ...... l in metastatic breast cancer.

@en

Circulating tumor cells versus ...... l in metastatic breast cancer.

@nl

type

label

Circulating tumor cells versus ...... l in metastatic breast cancer.

@en

Circulating tumor cells versus ...... l in metastatic breast cancer.

@nl

prefLabel

Circulating tumor cells versus ...... l in metastatic breast cancer.

@en

Circulating tumor cells versus ...... l in metastatic breast cancer.

@nl

P1433

Q53012804-0F40FF0F-6CF4-4D3C-B973-DB8FC0E1AA67

P1476

Q53012804-53AD211A-13D5-47C5-ADBA-1ACD5B83CDDC

P2093

Q53012804-00023F73-B725-4C12-AC37-C6FF5B6166C9

Q53012804-0061EF7A-242F-4976-A582-A381495753BA

Q53012804-16835FBD-98FC-4CC1-AF2D-4A88523FDC09

Q53012804-1ACF6990-8CF0-435C-A1EC-B97645C64A0D

Q53012804-4A48F6F6-700F-401F-8EC7-9406F2956C7E

Q53012804-541928B2-1565-4326-8616-8031FC4E2FA7

Q53012804-982BA9CF-492D-4F4F-AB26-7669181C271B

Q53012804-98429BFF-639E-4CBC-B882-9DE85A180D0B

Q53012804-B231208F-CB4F-436D-8F56-3B65CDD6AEE8

Q53012804-B4FA9C8A-B376-4E05-8B97-680719DCFDE9

P304

Q53012804-06CA83C3-23B5-4CE1-A667-A8D2F771B04C

P31

Q53012804-B2B22F7D-77EA-430E-8CC4-5E0AAA76CEDF

P356

Q53012804-9F54502D-0F87-447B-BFD0-421FD5528508

P407

Q53012804-A28156B5-CCC8-4FB2-B0B7-2034B73CF9DB

P433

Q53012804-693B5562-4C42-4B98-BE16-670621B4A45E

P478

Q53012804-941DCAE6-A8B0-42BE-A635-6F8FA7E2342A

P577

Q53012804-7D7FD77C-98A6-424E-98C2-C53B842FAE89

P698

Q53012804-24DE1212-4C99-447C-9E0D-E072FC0A6367

P356

1078-0432.CCR-05-1769

P1433

Clinical Cancer Research

P1476

Circulating tumor cells versus ...... l in metastatic breast cancer.

@en

P2093

Allison Stopeck

http://www.w3.org/2001/XMLSchema#string

Daniel F Hayes

http://www.w3.org/2001/XMLSchema#string

Ernest Borden

http://www.w3.org/2001/XMLSchema#string

G Thomas Budd

http://www.w3.org/2001/XMLSchema#string

Gerald V Doyle

http://www.w3.org/2001/XMLSchema#string

Jeri Matera

http://www.w3.org/2001/XMLSchema#string

Leon W M M Terstappen

http://www.w3.org/2001/XMLSchema#string

M Craig Miller

http://www.w3.org/2001/XMLSchema#string

Madeline Repollet

http://www.w3.org/2001/XMLSchema#string

Massimo Cristofanilli

http://www.w3.org/2001/XMLSchema#string

P304

6403-6409

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-05-1769

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17085652

http://www.w3.org/2001/XMLSchema#string